Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review

Summary

Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review

Neurocrine Biosciences, Inc. (Neurocrine) is a biopharmaceutical company, engaged in the discovery, development and commercialization of innovative pharmaceutical products for the treatment of neurological and endocrine-related diseases and disorders. The company has developed many of its product candidates targeted at world's largest pharmaceutical markets such as endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders.

Global Markets Direct's Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Neurocrine Biosciences, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • Overview
  • History
  • SWOT Analysis Overview
  • Overview
  • Neurocrine Biosciences, Inc. - Strengths
  • Strategic Alliances and Collaborations
  • Focused Research and Development Activities
  • Neurocrine Biosciences, Inc. - Weaknesses
  • Indiplon Further Development Doubtful
  • Operating Losses
  • Neurocrine Biosciences, Inc. - Opportunities
  • Multiple Therapeutic Applications
  • Extensive Product Pipeline
  • Changing Demographics
  • Rising Healthcare Expenditure in the US
  • Neurocrine Biosciences, Inc. - Threats
  • Intense Competition
  • Changing Political Climate in the US
  • Tightening of FDA's Regulatory Oversight
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Head Office
  • Financial Ratios
  • Capital Market Ratios
  • Annual Ratios
  • Interim Ratios
  • Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Neurocrine Biosciences, Inc., Key Facts
  • Neurocrine Biosciences, Inc., Key Ratios
  • Neurocrine Biosciences, Inc., Share Data
  • Neurocrine Biosciences, Inc., Key Facts
  • Neurocrine Biosciences, Inc., History
  • Neurocrine Biosciences, Inc., Key Employees
  • Neurocrine Biosciences, Inc., Key Employee Biographies
  • Neurocrine Biosciences, Inc., Ratios based on current share price
  • Neurocrine Biosciences, Inc., Annual Ratios
  • Neurocrine Biosciences, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Neurocrine Biosciences, Inc., Performance Chart (2004 - 2008)
  • Neurocrine Biosciences, Inc., Ratio Charts